Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
CALL
Direxion Daily Small Cap Bear 3x ETF
TZA
$243M
| $16.6M | 0.01% |
1,542
-1,386
| -47% | -$16.4M |
|
1152
PUT
ProShares UltraPro QQQ
TQQQ
$35.2B
| $16.5M | 0.01% |
6,163,200
-110,400
| -2% | -$273K |
|
|
OKS
1153
CALL
DELISTED
Oneok Partners LP
OKS
| $16.4M | 0.01% |
410,700
-33,200
| -7% | -$1.33M |
|
|
IMPV
1154
PUT
DELISTED
Imperva, Inc.
IMPV
| $16.4M | 0.01% |
305,400
+152,100
| +99% | +$7.06M |
|
|
ETP
1155
CALL
DELISTED
Energy Transfer Partners, L.P.
ETP
| $16.4M | 0.01% |
575,800
-120,600
| -17% | -$3.51M |
|
|
ACIA
1156
PUT
DELISTED
Acacia Communications Inc
ACIA
| $16.3M | 0.01% |
157,900
+71,300
| +82% | +$6.16M |
|
1157
PUT
Cal-Maine
CALM
$3.93B
| $16.3M | 0.01% |
422,500
-45,200
| -10% | -$1.95M |
|
1158
PUT
Realty Income
O
$59.4B
| $16.2M | 0.01% |
250,466
+116,100
| +86% | +$7.67M |
|
1159
CALL
T. Rowe Price
TROW
$24B
| $16.2M | 0.01% |
244,200
+7,800
| +3% | +$544K |
|
|
SHLD
1160
PUT
DELISTED
Sears Holding Corporation
SHLD
| $16.2M | 0.01% |
1,416,400
+249,200
| +21% | +$3.51M |
|
1161
CALL
Factset
FDS
$10.7B
| $16.2M | 0.01% |
100,100
+62,200
| +164% | +$10.7M |
|
|
STMP
1162
CALL
DELISTED
Stamps.com, Inc.
STMP
| $16.2M | 0.01% |
171,400
+102,100
| +147% | +$8.85M |
|
1163
CALL
Precigen
PGEN
$2.67B
| $16.2M | 0.01% |
583,303
+286,960
| +97% | +$7.59M |
|
|
NFX
1164
CALL
DELISTED
Newfield Exploration
NFX
| $16.2M | 0.01% |
372,700
-43,900
| -11% | -$1.93M |
|
1165
PUT
Zillow
Z
$8.21B
| $16.2M | 0.01% |
466,800
-489,300
| -51% | -$17.5M |
|
|
TSE
1166
CALL
DELISTED
Trinseo
TSE
| $16.2M | 0.01% |
+285,900
| New | +$15.2M |
|
1167
CALL
Urban Outfitters
URBN
$6.48B
| $16.1M | 0.01% |
467,800
+287,800
| +160% | +$9.43M |
|
1168
Rio Tinto
RIO
$173B
| $16.1M | 0.01% |
483,248
+313,641
| +185% | +$9.99M |
|
1169
PUT
Cleveland-Cliffs
CLF
$6.54B
| $16.1M | 0.01% |
2,743,900
-1,387,300
| -34% | -$9.05M |
|
1170
CALL
Campbell Soup
CPB
$7B
| $16M | 0.01% |
293,000
-176,700
| -38% | -$10.7M |
|
1171
CALL
Core Laboratories
CLB
$549M
| $16M | 0.01% |
142,600
+26,700
| +23% | +$3.08M |
|
1172
CALL
Exelixis
EXEL
$13.9B
| $16M | 0.01% |
1,251,900
+23,800
| +2% | +$257K |
|
|
GRA
1173
CALL
DELISTED
W.R. Grace & Co.
GRA
| $16M | 0.01% |
216,900
+52,900
| +32% | +$3.99M |
|
|
ATHN
1174
PUT
DELISTED
Athenahealth, Inc.
ATHN
| $16M | 0.01% |
126,500
+38,400
| +44% | +$4.88M |
|
1175
Illumina
ILMN
$34.1B
| $15.9M | 0.01% |
89,738
+35,435
| +65% | +$5.67M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.99B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,278 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.